COPD Archives - Express Pharma

COPD diagnosed prevalent cases across 7MM to reach 38.02 million in 2033, forecasts GlobalData

EMA approval of Sanofi/Regeneron’s Dupixent fills biologic gap in COPD: GlobalData

AstraZeneca receives CDSCO approval to market its inhalation aerosol

Lupin partners with Cost Plus Drugs, COPD Foundation

Lupin receives approval from TGA Australia for Tiotropium dry powder

Lupin signs MoU with Maha Govt to combat cardiovascular diseases and COPD

Zydus gets USFDA approval for Roflumilast Tablets, 250 mcg

Cipla launches Spirofy, strengthens its lung leadership position by facilitating early diagnosis for COPD1

Lupin gets UK marketing authorisation for Luforbec 100/6 µg pMDI

Lupin launches generic version of Brovana in US